Alternative splicing of HER2: a novel mediator of EGFR TKI resistance

Lignende værker

• Response to HER2 Inhibition in a Patient With Brain Metastasis With EGFR TKI Acquired Resistance and an HER2 Amplification
  af: Meedendorp, Arenda D., et al.
  Udgivet: (2018)
• Hormone gene signature guides a novel therapeutic opportunity to improve sensitivity to HER family inhibition in lung cancer
  af: Yochum, Zachary A., et al.
  Udgivet: (2020)
• EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies
  af: Zhu, Xuan, et al.
  Udgivet: (2019)
• Upregulation of Bcl2 in NSCLC with acquired resistance to EGFR-TKI
  af: Cheong, Hio Teng, et al.
  Udgivet: (2018)
• Novel Curcumin Analogs to Overcome EGFR-TKI Lung Adenocarcinoma Drug Resistance and Reduce EGFR-TKI-induced GI Adverse Effects
  af: Wada, Koji, et al.
  Udgivet: (2015)